Transmission of viral hepatitis by kidney transplantation: Donor evaluation and transplant policies (Part 2: Hepatitis C virus)

Transplant Infectious Disease

Volumn 4, Issue 3, 2002, Pages 124-131

  Natov, S N ^a,b,c   Pereira, B J G ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c Northeast Specialty Hospital   (United States)

Author keywords

Hepatitis C; Kidney transplantation; Organ donor; Viral hepatitis

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ANTIBODY DETECTION; CADAVER KIDNEY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE POLICY; HEART TRANSPLANTATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MORBIDITY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SAFETY; SCREENING; SERODIAGNOSIS; SURGICAL MORTALITY;

CADAVER; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; KIDNEY TRANSPLANTATION; PREVALENCE; TISSUE DONORS;

EID: 0036758588     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3062.2002.t01-2-01002.x     Document Type: Review

References (51)

1. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology 1991: 14: 381-388.
2. Choo Q, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989: 244:358-362.
3. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989: 244:362-364.
4. Okamoto H, Okada S, Sugiyama Y, et al. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions. J General Virol 1991: 72: 2697-2704.
5. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J General Virol 1992: 73: 673-679.
6. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major region genotypes and a series of subtypes by phylogenetic analysis of the NS5 region. J General Virol 1993: 74: 2391-2399.
7. Pereira BJG, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997: 51: 981-999.
8. Alter M, Hadler SC, Judson FN, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990: 264: 2231-2235.
9. Pereira BJG, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991: 325:454-460.
10. Pereira BJG, Milford EL, Kirkman RL, et al. Prevalence of HCV RNA in hepatitis C antibody positive cadaver organ donors and their recipients. N Engl J Med 1992: 327: 910-915.
11. Weiner AJ, Kuo G, Bradley DW, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990: 335: 1-3.
12. Sugitani M, Inchaupse G, Shindo M, Prince AM. Sensitivity of serological assays to identify blood donors with hepatitis C viremia. Lancet 1992: 339:1018-1019.
13. Farci P, Alter HJ, Wong D, et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991: 325: 98-104.
14. Simmonds P, Zhang LQ, Watson HG, et al. Hepatitis C quantification and sequencing in blood products, hemophiliacs, and drug users. Lancet 1990: 336: 1469-1471.
15. Ulrich PP, Romeo JM, Lane PK, Kelly I, Danial LJ, Vyas GN. Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase. J Clin Invest 1990: 86:1609-1614.
16. Lau JYN, Davis GL, Orito E, Qian KP, Mizokami M. Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infection. J Hepatol 1993:17:253-257.
17. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989: 339: 237-238.
18. Busch MP, Wilber JC, Johnson PJ, Tobler L, Evans CS. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 1992: 32: 420-425.
19. Urdea MS, Horn T, Fultz TJ, et al. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. Nucleic Acids Res Symp Series 1991: 24:197-200.
20. Lau JYN, Davis GL, Kniffen J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993: 341: 1501-1504.
21. Laquaglia MP, Tolkoff-Rubin NE, Dienstag JL, et al. Impact of hepatitis on renal transplantation. Transplantation 1981: 32: 504-507.
22. Weir MR, Kirkman RL, Strom TB, Tilney NL. Liver disease in recipients of long-surviving renal allografts. Kidney Int 1985: 28:839-844.
23. Roth D, Fernandez JA, Babischkin S, et al. Detection of hepatitis C infection among cadaver organ donors: Evidence for low transmission of disease. Ann Intern Med 1992:117:470-475.
24. Huang CC, Lai MK, Lin MW, Pao CC, Fang JT, Yao DS. Transmission of hepatitis C virus by renal transplantation. Transplant Proc 1993:25:1474-1475.
25. Vincenti F, Lake J, Wright T, Kuo G, Weber P, Stempel C. Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients. Transplantation 1993: 55:674-675.
26. Gomez E, Aguado S, Gago E, et al. A study of renal transplants obtained from anti-HCV positive donors. Transplant Proc 1991: 23: 2654-2655.
27. Triolo G, Squiccimarro G, Baldi M, et al. Antibodies to hepatitis C virus in kidney transplantation. Nephron 1992: 61: 276-277.
28. Le For W, Wright C, Shires D, Kahana L, Spoto E, Ackermann J. A preliminary outcome evaluation of the impact of HCV-AB studied in 521 cadaver vascular organ donors over a 6 year period, American Society of Transplant Physicians, 10th Annual Meeting, Chicago, May 28-29,1991.
29. Aeder MI, Shield CF, Tegtmeier GE, et al. The incidence and clinical impact of hepatitis C virus (HCV) positive donors in cadaveric transplantation. Transplant Proc 1993: 25: 1469-1471.
30. Tesi R, Waller K, Morgan C, et al. Transmission of hepatitis C by kidney transplantation - The risks. Transplantation 1994:57:826-831.
31. Wreghitt TG, Gray JJ, Allain JP, et al. Transmission of hepatitis C virus by organ transplantation in the United Kingdom. J Hepatol 1994: 20: 768-772.
32. Prados MC, Franco A, Perdiguero M, Munoz C, De La Sen ML, Olivares J. Transmission of hepatitis C virus by kidney transplantation. Transplant Proc 1992: 24: 2650-2651.
33. Pirsch JD, Heisey D, D'allesandro AM, Knechtle SJ, Sollinger HW, Belzer FO. Transplantation of hepatitis C (HCV) kidneys: Defining the risks. 14th Annual Meeting of the American Society of Transplant Physicians, Chicago, May 14-17,1995.
34. Preiksaitis JK, Cockfield SM, Fenton JM, Burton NI, Chui LWL. Serologic responses to hepatitis C virus in solid organ transplant recipients. Transplantation 1997: 64: 1775-1780.
35. Pereira BJG, Wright TL, Schmid CH, et al. Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: A U.S Natl Collaborative Study Kidney Int 1994: 46: 886-892.
36. Mendez R, Aswad S, Bogaard T, et al. Donor hepatitis C antibody virus testing in renal transplantation. Transplant Proc 1993: 25: 1487-1490.
37. Tesi RJ, Waller MK, Morgan CJ, et al. Use of low-risk HCV-positive donors for kidney transplantation. Transplant Proc 1993: 25: 1472-1473.
38. Zucker K, Cirocco R, Roth D, et al. Depletion of hepatitis C virus from procured kidneys using pulsatile perfusion preservation. Transplantation 1994: 57: 832-840.
39. Miranda B, Sanchez M, Sergovia C, Felipe C, Matesanz R. Characteristics of the donors in Spain 1992. 8th Congress of European Transplant Coordinators Organization, Rodos, Greece, October 23-25,1993.
40. Pereira BJG, Wright TL, Schmid CH, Levy AS. For The New England Organ Bank Hepatitis C Study Group. A controlled study of hepatitis C transmission by organ transplantation. Lancet 1995: 345: 484-487.
41. Bouthot BA, Murthy BVR, Schmid CH, Levey AS, Pereira BJG. Long-term follow-up of hepatitis C virus infection among organ transplant recipients: Implications for policies on organ procurement. Transplantation 1997: 63:849-853.
42. Mendez R, El-Shahawy M, Obispo E, Aswad S, Mendex RG. Four years follow up of hepatitis C positive kidneys into hepatitis C negative recipients-prospective study. J Am Soc Nephrol 1995: 6:1105.
43. Anonymous. Public health service inter-agency guidelines for screening donors of blood, plasma, organs, tissues and semen for evidence of hepatitis B and hepatitis C. MMWR 1991:40:1-17.
44. Pereira B, Levey A. Hepatitis C infection in cadaver organ donors: Strategies to reduce transmission of infection and prevent organ waste. Pediatr Nephrol 1995: 9: S23-S28.
45. Morales JM, Campistol JM, Castellano G, et al. Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 1995:47:236-240.
46. Natov SN, Lau JYN, Ruthazer R, et al. HCV genotype does not affect patient survival among renal transplant candidates. Kidney Int 1999: 56: 700-706.
47. Farci P, Alter HJ, Govindarajan S, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992:258:135-140.
48. Widell A, Mansson S, Persson NH, Thysell H, Hermodsson S, Blohme I. Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation 1995: 60:642-647.
49. Oldach D, Constantine N, Schweitzer E, et al. Clinical and virological outcomes in hepatitis C virus (HCV)-infected renal transplant recipients. 14th Annual Meeting of the American Society of Transplant Physicians, Chicago, May 14-17,1995.
50. Morales Jm, Campistol JM, Andres A, et al. Policies concerning the use of kidneys from donors infected with hepatitis C virus. Nephrol Dial Transplant 2000: 15: 71-73.
51. Sanchez-Tapias JM, Rodes J. Dilemmas of organ transplantation from anti-HCV-positive donors. Lancet 1995: 345: 469-470.